QCOM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Qualcomm Inc (QCOM) is not a good buy for a beginner, long-term investor at this time. The stock faces significant headwinds in its core handset market, with analysts downgrading ratings and lowering price targets. Additionally, hedge funds are selling, and technical indicators suggest limited upside potential. While the company is making efforts to diversify, near-term catalysts are lacking, and financial performance shows declining profitability metrics. Given the user's impatience and unwillingness to wait for optimal entry points, holding off on investing in QCOM is recommended.
The MACD histogram is positive at 1.161, indicating bullish momentum, but it is contracting. RSI is neutral at 52.571, and moving averages are converging, suggesting no strong trend. The stock is trading near its pivot level of 132.952, with resistance at 137.551 and support at 128.353. Overall, technical indicators do not provide a compelling buy signal.
Revenue increased by 5.00% YoY in Q1 2026, reflecting some growth in the company's top line. The company is working on diversifying its revenue streams into automotive, PCs, and data centers.
Analysts have downgraded the stock due to challenges in the handset market, memory headwinds, and lack of near-term catalysts. Hedge funds are selling, and insiders are neutral. The stock has a high chance of declining in the short term (-1.28% in the next day, -3.88% in the next week, and -15.13% in the next month). Financial metrics such as net income, EPS, and gross margin have declined YoY.
In Q1 2026, Qualcomm's revenue increased by 5.00% YoY to $12.25 billion. However, net income dropped by -5.53% YoY to $3.004 billion, EPS declined by -1.77% YoY to 2.78, and gross margin fell by -2.19% YoY to 54.55%. These figures indicate declining profitability despite revenue growth.
Analysts have a negative outlook on Qualcomm, with multiple downgrades and reduced price targets. Barclays reinstated coverage with an Underweight rating and a $130 price target. UBS lowered its price target to $150 from $160, maintaining a Neutral rating. BNP Paribas downgraded the stock to Neutral from Outperform, with a $120 price target. JPMorgan downgraded it to Neutral from Overweight, with a $140 price target, citing risks in the handset business and lack of catalysts.
